We do have COVID-19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Tu carrito está vacío

MA 1001

Non-Pneumatic Anti Shock Garment

The Non-Pneumatic Anti-Shock Garment (NASG) is clinically proven to reverse shock in the case of massive postpartum hemorrhage. For all midwives, nurses and obstetricians interested in a CE-marked device to reduce maternal death, this product is essential to have in ambulances, in clinics and in hospitals.

  • Custom manufacturing runs of small or large sized NASGs, each with a serial number
  • Original PATH design specifications
  • Maternova instructional booklet in French, English and Spanish

THE PROBLEM

One postpartum hemorrhage death occurs every 4 minutes. One of the key issues is the speed with which an anemic woman can lose her life if she is not provided life-saving care. Without intervention, a woman who is already malnourished or anemic can go into hypovolemic shock - the loss of more than 20% of the body’s blood supply - which results in an insufficient amount of blood being pumped throughout the body. Hypovolemic shock can lead to organ failure and even death in a matter of a few hours.  Often women die in transit to a higher-level facility. But what if you could ‘buy time’—stabilizing the woman until she reaches a higher level facility? This is the idea behind non-pneumatic anti-shock garments and the NASG.

THE SOLUTION

The Non-Pneumatic Anti-Shock Garment (NASG) is an external pressure suit that is used to stabilize a woman experiencing bleeding after delivery of a baby.

A large, hard sphere sewn into the abdominal section of the NASG presses onto the uterus and helps to stop hemorrhage and reverse shock in women. The NASG has been proven in clinical trials and is used when transporting women on an ambulance or to stabilize a woman awaiting blood transfusion in a hospital.

Clinical trials in Egypt and Nigeria established how using an anti-shock garment intervention compares to current practice. Two key studies of an anti-shock garment came out in late 2009—one from Nigeria and one from Egypt. Maternal mortality and morbidity was lower with the use of an anti-shock garment. In both studies, “the measured blood loss was significantly lower for women treated with the NASG: 78% lower in Nigeria and 50% lower in Egypt.”

We believe that every clinic, emergency room, ship, ambulance and hospital, and every midwifery home and maternity waiting home should have an NASG.  We also believe every medical student should be trained to stop hemorrhage.

Size

The Non-Pneumatic Anti-Shock Garment (NASG) is clinically proven to reverse shock in the case of massive postpartum hemorrhage. For all midwives, nurses and obstetricians interested in a CE-marked device to reduce maternal death, this product is essential to have in ambulances, in clinics and in hospitals.

  • Custom manufacturing runs of small or large sized NASGs, each with a serial number
  • Original PATH design specifications
  • Maternova instructional booklet in French, English and Spanish

THE PROBLEM

One postpartum hemorrhage death occurs every 4 minutes. One of the key issues is the speed with which an anemic woman can lose her life if she is not provided life-saving care. Without intervention, a woman who is already malnourished or anemic can go into hypovolemic shock - the loss of more than 20% of the body’s blood supply - which results in an insufficient amount of blood being pumped throughout the body. Hypovolemic shock can lead to organ failure and even death in a matter of a few hours.  Often women die in transit to a higher-level facility. But what if you could ‘buy time’—stabilizing the woman until she reaches a higher level facility? This is the idea behind non-pneumatic anti-shock garments and the NASG.

THE SOLUTION

The Non-Pneumatic Anti-Shock Garment (NASG) is an external pressure suit that is used to stabilize a woman experiencing bleeding after delivery of a baby.

A large, hard sphere sewn into the abdominal section of the NASG presses onto the uterus and helps to stop hemorrhage and reverse shock in women. The NASG has been proven in clinical trials and is used when transporting women on an ambulance or to stabilize a woman awaiting blood transfusion in a hospital.

Clinical trials in Egypt and Nigeria established how using an anti-shock garment intervention compares to current practice. Two key studies of an anti-shock garment came out in late 2009—one from Nigeria and one from Egypt. Maternal mortality and morbidity was lower with the use of an anti-shock garment. In both studies, “the measured blood loss was significantly lower for women treated with the NASG: 78% lower in Nigeria and 50% lower in Egypt.”

We believe that every clinic, emergency room, ship, ambulance and hospital, and every midwifery home and maternity waiting home should have an NASG.  We also believe every medical student should be trained to stop hemorrhage.

Noticias y actualizaciones

Regístrate gratis para obtener lo último en ventas, nuevos lanzamientos y más…

maternal and newborn health news